Warp Drive Bio Inc., was launched in 2012 by Third Rock Ventures in partnership with the French drug giant Sanofi and was acquired in mid-October 2018 by California-based Revolution Medicines Inc. Organized around using a genomic search engine and customized search queries to reveal hidden natural products based on genomic signature, Warp Drive Bio is exploiting the molecules and mechanisms of nature to create transformative medicines. The company operates on the core principle that nature is the worldÂ’s most powerful inventor of new drugs, unconstrained by the mechanistic and synthetic limitations of traditional medicinal chemistry. Warp Drive Bio is deploying its proprietary Genomic Mining and SMART(TM) (Small Molecule Assisted Receptor Targeting) platforms to discover novel medicines that have the potential to make a significant difference in patientsÂ’ lives. The company was launched through a strategic partnership with Sanofi and has significant financing also from two leading VC entities. In October 2017 a significant Working Relationship was announced with Roche addressing a novel antibiotic class
